Elizabeth M Swisher (Elizabeth Swisher)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 21

Top Venues

Nature communications

Cancer research

Clinical cancer research : an official journal of the American Association for Cancer Research

Proceedings of the National Academy of Sciences of the United States of America

University of Washington

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Washington Jul 15 1999

United States

Professor :: Ob/Gyn

Publications

Elena Giudice, Tzu-Ting Huang, Jayakumar R Nair, Grant Zurcher, Ann McCoy, Darryl Nousome, Marc R Radke, Elizabeth M Swisher, Stanley Lipkowitz, Kristen R Ibanez, Duncan Donohue, Tyler Malys, Min-Jung Lee, Bernadette Redd, Elliot Levy, Shraddha Rastogi, Nahoko Sato, Jane B Trepel, Jung-Min Lee
The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial. Nature communications 15 (1) (2024)
Elena Giudice, Tzu-Ting Huang, Jayakumar R Nair, Grant Zurcher, Ann McCoy, Darryl Nousome, Marc R Radke, Elizabeth M Swisher, Stanley Lipkowitz, Kristen R Ibanez, Duncan Donohue, Tyler Malys, Min-Jung Lee, Bernadette Redd, Elliot Levy, Shraddha Rastogi, Nahoko Sato, Jane B Trepel, Jung-Min Lee
The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial. Nature communications 15 (1) (2024)
Elena Giudice, Tzu-Ting Huang, Jayakumar R Nair, Grant Zurcher, Ann McCoy, Darryl Nousome, Marc R Radke, Elizabeth M Swisher, Stanley Lipkowitz, Kristen R Ibanez, Duncan Donohue, Tyler Malys, Min-Jung Lee, Bernadette Redd, Elliot Levy, Shraddha Rastogi, Nahoko Sato, Jane B Trepel, Jung-Min Lee
The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial. Nature communications 15 (1) (2024)
Nitasha Gupta, Tzu-Ting Huang, Jayakumar R Nair, Daniel An, Grant Zurcher, Erika J Lampert, Ann McCoy, Ashley Cimino-Mathews, Elizabeth M Swisher, Marc R Radke, Christina M Lockwood, Jonathan B Reichel, Chih-Yuan Chiang, Kelli M Wilson, Ken Chih-Chien Cheng, Darryl Nousome, Jung-Min Lee
BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor-resistant BRCA -mutant ovarian cancer. Science translational medicine 15 (701) (2023)
Zhiyan Silvia Liu, Sayantani Sinha, Maxwell Bannister, Axia Song, Erica Arriaga-Gomez, Alexander J McKeeken, Elizabeth A Bonner, Benjamin K Hanson, Martina Sarchi, Kouhei Takashima, Dawei Zong, Victor M Corral, Evan Nguyen, Jennifer Yoo, Wannasiri Chiraphapphaiboon, Cassandra Leibson, Matthew C McMahon, Sumit Rai, Elizabeth M Swisher, Zohar Sachs, Srinivas Chatla, Derek L Stirewalt, H Joachim Deeg, Tomasz Skorski, Eirini P Papapetrou, Matthew J Walter, Timothy A Graubert, Sergei Doulatov, Stanley C Lee, Hai Dang Nguyen
R-loop accumulation in spliceosome mutant leukemias confers sensitivity to PARP1 inhibition by triggering transcription-replication conflicts. Cancer research (2023)
Felipe Batalini, Niya Xiong, Nabihah Tayob, Madeline Polak, Julia Eismann, Lewis C Cantley, Geoffrey I Shapiro, Viktor Adalsteinsson, Eric P Winer, Panagiotis A Konstantinopoulos, Alan D' Andrea, Elizabeth M Swisher, Ursula A Matulonis, Gerburg M Wulf, Erica L Mayer
Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (8) (2022)
Tara Coffin, Deborah J Bowen, Elizabeth M Swisher, Karen H Lu, Nadine Rayes, Barbara S Norquist, Stephanie V Blank, Douglas A Levine, Jamie Nadine Bakkum-Gamez, Gini F Fleming, Olufunmilayo I Olopade, Alan D' Andrea, Denise R Nebgen, Christine B Peterson, Mark F Munsell, Kathleen Gavin, Rebecca Lechner, Jamie Crase, Deborah Polinsky, Iris L Romero
An Accessible Communication System for Population-Based Genetic Testing: Development and Usability Study. JMIR formative research 6 (10) (2022)
Tara Coffin, Deborah J Bowen, Karen H Lu, Elizabeth M Swisher, Nadine Rayes, Barbara S Norquist, Stephanie V Blank, Douglas A Levine, Jamie Nadine Bakkum-Gamez, Gini F Fleming, Olufunmilayo I Olopade, Iris L Romero, Alan D' Andrea, Denise R Nebgen, Christine B Peterson, Mark F Munsell, Kathleen Gavin, Jamie Crase, Deborah Polinsky, Rebecca Lechner
Using Social Media to Facilitate Communication About Women's Testing: Tool Validation Study. JMIR formative research 6 (9) (2022)
Rohit Prakash, Yashpal Rawal, Meghan R Sullivan, McKenzie K Grundy, Hélène Bret, Michael J Mihalevic, Hayley L Rein, Jared M Baird, Kristie Darrah, Fang Zhang, Raymond Wang, Tiffany A Traina, Marc R Radke, Scott H Kaufmann, Elizabeth M Swisher, Raphaël Guérois, Mauro Modesti, Patrick Sung, Maria Jasin, Kara A Bernstein
Homologous recombination-deficient mutation cluster in tumor suppressor RAD51C identified by comprehensive analysis of cancer variants. Proceedings of the National Academy of Sciences of the United States of America 119 (38) (2022)
Shogo Shigeta, Goldie Y L Lui, Reid Shaw, Russell Moser, Kay E Gurley, Grace Durenberger, Rachele Rosati, Robert L Diaz, Tan A Ince, Elizabeth M Swisher, Carla Grandori, Christopher J Kemp
Targeting BET Proteins BRD2 and BRD3 in Combination with PI3K-AKT Inhibition as a Therapeutic Strategy for Ovarian Clear Cell Carcinoma. Molecular cancer therapeutics 20 (4) (2021)
Elizabeth M Swisher, Tanya T Kwan, Amit M Oza, Anna V Tinker, Isabelle L Ray-Coquard, Ana Oaknin, Robert L Coleman, Carol Aghajanian, Gottfried E Konecny, David M O'Malley, Alexandra Leary, Diane Provencher, Stephen Welch, Lee-May Chen, Andrea E Wahner Hendrickson, Ling Ma, Prafull Ghatage, Rebecca S Kristeleit, Oliver Dorigo, Ashan Musafer, Scott H Kaufmann, Julia A Elvin, Douglas I Lin, Setsuko K Chambers, Erin Dominy, Lan-Thanh Vo, Sandra Goble, Lara Maloney, Heidi Giordano, Thomas Harding, Alexander Dobrovic, Clare L Scott, Kevin K Lin, Iain A McNeish
Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2). Nature communications 12 (1) (2021)
Ksenija Nesic, Olga Kondrashova, Rachel M Hurley, Cordelia D McGehee, Cassandra J Vandenberg, Gwo-Yaw Ho, Elizabeth Lieschke, Genevieve Dall, Nirashaa Bound, Kristy Shield-Artin, Marc Radke, Ashan Musafer, Zi Qing Chai, Mohammad Reza Eftekhariyan Ghamsari, Maria I Harrell, Damien Kee, Inger Olesen, Orla McNally, Nadia Traficante, null Australian Ovarian Cancer Study, Anna De Fazio, David D L Bowtell, Elizabeth M Swisher, S John Weroha, Katia Nones, Nicola Waddell, Scott H Kaufmann, Alexander Dobrovic, Matthew J Wakefield, Clare L Scott
Acquired RAD51C Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian Carcinoma. Cancer research 81 (18) (2021)
Yuezheng Zhang, Brendan F Kohrn, Ming Yang, Daniela Nachmanson, T Rinda Soong, I-Hsiu Lee, Yong Tao, Hans Clevers, Elizabeth M Swisher, Teresa A Brentnall, Lawrence A Loeb, Scott R Kennedy, Jesse J Salk, Kamila Naxerova, Rosa Ana Risques
PolyG-DS: An ultrasensitive polyguanine tract-profiling method to detect clonal expansions and trace cell lineage. Proceedings of the National Academy of Sciences of the United States of America 118 (31) (2021)
Meghan R Sullivan, Rohit Prakash, Yashpal Rawal, Weibin Wang, Patrick Sung, Marc R Radke, Scott H Kaufmann, Elizabeth M Swisher, Kara A Bernstein, Maria Jasin
Long-term survival of an ovarian cancer patient harboring a RAD51C missense mutation. Cold Spring Harbor molecular case studies 7 (2) (2021)
E Gabriela Chiorean, Katherine A Guthrie, Philip A Philip, Elizabeth M Swisher, Florencia Jalikis, Michael J Pishvaian, Jordan D Berlin, Marcus S Noel, Jennifer M Suga, Ignacio Garrido-Laguna, Dana Backlund Cardin, Marc R Radke, Mai Duong, Shay Bellasea, Andrew M Lowy, Howard S Hochster
Randomized Phase II Study of PARP Inhibitor ABT-888 (Veliparib) with Modified FOLFIRI versus FOLFIRI as Second-line Treatment of Metastatic Pancreatic Cancer: SWOG S1513. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)
Erika J Lampert, Alexandra S Zimmer, Michelle Padget, Ashley Cimino-Mathews, Jayakumar R Nair, Yingmiao Liu, Elizabeth M Swisher, James W Hodge, Andrew B Nixon, Erin Nichols, Mohammad Hadi Bagheri, Elliott Levy, Marc R Radke, Stanley Lipkowitz, Christina M Annunziata, Janis M Taube, Seth M Steinberg, Jung-Min Lee
Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (16) (2020)
Anniina Farkkila, Doga C Gulhan, Julia Casado, Connor A Jacobson, Huy Nguyen, Bose Kochupurakkal, Zoltan Maliga, Clarence Yapp, Yu-An Chen, Denis Schapiro, Yinghui Zhou, Julie R Graham, Bruce J Dezube, Pamela N Munster, Sandro Santagata, Elizabeth Garcia, Scott Rodig, Ana Lako, Dipanjan Chowdhury, Geoffrey I Shapiro, Ursula A Matulonis, Peter J Park, Sampsa Hautaniemi, Peter Karl Sorger, Elizabeth M Swisher, Alan D' Andrea, Panagiotis A Konstantinopoulos
Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer. Nature communications 11 (1) (2020)
Anniina Farkkila, Doga C Gulhan, Julia Casado, Connor A Jacobson, Huy Nguyen, Bose Kochupurakkal, Zoltan Maliga, Clarence Yapp, Yu-An Chen, Denis Schapiro, Yinghui Zhou, Julie R Graham, Bruce J Dezube, Pamela N Munster, Sandro Santagata, Elizabeth Garcia, Scott Rodig, Ana Lako, Dipanjan Chowdhury, Geoffrey I Shapiro, Ursula A Matulonis, Peter J Park, Sampsa Hautaniemi, Peter Karl Sorger, Elizabeth M Swisher, Alan D' Andrea, Panagiotis A Konstantinopoulos
Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer. Nature communications 11 (1) (2020)
Cassandra L Moyer, Jennifer Ivanovich, Jessica L Gillespie, Rachel Doberstein, Marc R Radke, Marcy E Richardson, Scott H Kaufmann, Elizabeth M Swisher, Paul J Goodfellow
Rare BRIP1 Missense Alleles Confer Risk for Ovarian and Breast Cancer. Cancer research 80 (4) (2019)
Pyoung Hwa Park, Tomomi M Yamamoto, Hua Li, Allen L Alcivar, Bing Xia, Yifan Wang, Andrea J Bernhardy, Kristen M Turner, Andrew V Kossenkov, Zachary L Watson, Kian Behbakht, Silvia Casadei, Elizabeth M Swisher, Paul S Mischel, Neil Johnson, Benjamin G Bitler
Amplification of the Mutation-Carrying BRCA2 Allele Promotes RAD51 Loading and PARP Inhibitor Resistance in the Absence of Reversion Mutations. Molecular cancer therapeutics 19 (2) (2019)
Barbara S Norquist, Elizabeth M Swisher, Rachel L Yung
Preventing Breast Cancer in High-Risk Women: Is There Still a Role for Oophorectomy? JNCI cancer spectrum 4 (1) (2019)

Elizabeth M Swisher.css-eqlu8i{font-size:small;padding-left:4px;} (Elizabeth Swisher)

Publication Activity (10 Years)

Top Topics

Top Venues

Elizabeth M Swisher (Elizabeth Swisher)